Scientech Research LLC Bio N Tech Se Transaction History
Scientech Research LLC
- $485 Billion
- Q2 2024
A detailed history of Scientech Research LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Scientech Research LLC holds 14,022 shares of BNTX stock, worth $1.56 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
14,022Holding current value
$1.56 Million% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
324Shares Held
39.1MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.31MShares$922 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$531 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$486 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$325 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$210 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $26.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...